Antiviral therapy of hepatitis C with 1 genotype after liver transplantation

Chronic HCV infection is the leading cause of liver transplantation in adults in developed countries. Unfortunately, the reinfection of the graft inevitably occurs in  all patients with persistent replication of the virus. Against the background of the  necessary immunosuppressive therapy, the progr...

Full description

Saved in:
Bibliographic Details
Main Authors: O. M. Tsiroulnikova, D. V. Umrik
Format: Article
Language:Russian
Published: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2018-09-01
Series:Вестник трансплантологии и искусственных органов
Subjects:
Online Access:https://journal.transpl.ru/vtio/article/view/919
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691188748091392
author O. M. Tsiroulnikova
D. V. Umrik
author_facet O. M. Tsiroulnikova
D. V. Umrik
author_sort O. M. Tsiroulnikova
collection DOAJ
description Chronic HCV infection is the leading cause of liver transplantation in adults in developed countries. Unfortunately, the reinfection of the graft inevitably occurs in  all patients with persistent replication of the virus. Against the background of the  necessary immunosuppressive therapy, the progression of the disease accelerates,  leading to rapid decompensation of the liver. Antiviral therapy significantly improves  the results of transplantation, but the use of standard interferon-based  regimens is associated with low efficacy (no more than 30% for the most common 1  genotype of the virus) and poor tolerance. The article describes new interferon- free oral regimens used to treat the recurrence of HCV infection of 1 genotype.
format Article
id doaj-art-c5e60e1c1c1944e39086bcd6953447ab
institution DOAJ
issn 1995-1191
language Russian
publishDate 2018-09-01
publisher Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
record_format Article
series Вестник трансплантологии и искусственных органов
spelling doaj-art-c5e60e1c1c1944e39086bcd6953447ab2025-08-20T03:21:06ZrusFederal Research Center of Transplantology and Artificial Organs named after V.I.ShumakovВестник трансплантологии и искусственных органов1995-11912018-09-0120310511510.15825/1995-1191-2018-3-105-115728Antiviral therapy of hepatitis C with 1 genotype after liver transplantationO. M. Tsiroulnikova0D. V. Umrik1V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian Federation I.M. Sechenov First Moscow State Medical University of the Ministry of Healthcare of the Russian Federation (Sechenovsky University)V.I. Shumakov National Medical Research Center of Transplantology and Artificial Organs of the Ministry of Healthcare of the Russian FederationChronic HCV infection is the leading cause of liver transplantation in adults in developed countries. Unfortunately, the reinfection of the graft inevitably occurs in  all patients with persistent replication of the virus. Against the background of the  necessary immunosuppressive therapy, the progression of the disease accelerates,  leading to rapid decompensation of the liver. Antiviral therapy significantly improves  the results of transplantation, but the use of standard interferon-based  regimens is associated with low efficacy (no more than 30% for the most common 1  genotype of the virus) and poor tolerance. The article describes new interferon- free oral regimens used to treat the recurrence of HCV infection of 1 genotype.https://journal.transpl.ru/vtio/article/view/919chronic hepatitis crelapseliver transplantationdirect antiviral actionresistant virologic response.
spellingShingle O. M. Tsiroulnikova
D. V. Umrik
Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
Вестник трансплантологии и искусственных органов
chronic hepatitis c
relapse
liver transplantation
direct antiviral action
resistant virologic response.
title Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
title_full Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
title_fullStr Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
title_full_unstemmed Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
title_short Antiviral therapy of hepatitis C with 1 genotype after liver transplantation
title_sort antiviral therapy of hepatitis c with 1 genotype after liver transplantation
topic chronic hepatitis c
relapse
liver transplantation
direct antiviral action
resistant virologic response.
url https://journal.transpl.ru/vtio/article/view/919
work_keys_str_mv AT omtsiroulnikova antiviraltherapyofhepatitiscwith1genotypeafterlivertransplantation
AT dvumrik antiviraltherapyofhepatitiscwith1genotypeafterlivertransplantation